Global partnerships Strategic collaboration potential with Skintech Medical Cosmetic Clinic in India and Skintech Green Ltd in Kenya suggests opportunities to co-develop and distribute collagen-based wound care products across regional hospital networks and clinics.

Vet to Human Expansion Existing Kollavet veterinary collagen products indicate a pathway to leverage cross-category sales, expanding into human wound care while leveraging existing manufacturing and regulatory capabilities to cross-sell to veterinary and human healthcare channels.

Regulatory Readiness FDA-compliant and ISO 13485 certified operations support accelerated market entry for additional wound care formulations and potential OTC/HCP channels, reducing regulatory hurdles for distributors and partners.

Mid-market Scale Revenue in the low tens of millions with a mid-size employee base signals agility and room for rapid growth through channel partners, contract manufacturers, and regional distributors targeting clinics, hospitals, and long-term care facilities.

E-commerce & Accessibility Existing online presence and upcoming human OTC availability present digital sales opportunities through direct-to-consumer and B2B e-commerce platforms, enabling cross-border distribution and prescription-to-OTC transitions with partner enablement.